Systemic and forearm haemodynamic and metabolic effects of racemic propranolol or D-propranolol in healthy subjects
- PMID: 7249547
- DOI: 10.1042/cs0600675
Systemic and forearm haemodynamic and metabolic effects of racemic propranolol or D-propranolol in healthy subjects
Abstract
1. The immediate haemodynamic and metabolic effects of intravenous administration of DL-propranolol and D-propranolol were studied in healthy male subjects at rest and during dynamic forearm exercise. The dose of DL-propranolol and of D-propranolol was 0.1 and 1.0 mg/kg body weight respectively. 2. DL-Propranolol reduced heart rate significantly at rest, during forearm exercise and post-exercise, whereas D-propranolol had a lesser effect on heart rate which was significant only at the end of the exercise period. Arterial blood pressure and forearm blood flow were unchanged after either drug. 3. Both drugs reduced the release of lactate from the exercising forearm. Forearm exchange of oxygen, glucose, free fatty acids and triglycerides remained unchanged. 4. The arterial blood glucose concentration increased after D-propranolol, but was unchanged after DL-propranolol. The arterial serum free fatty acid concentration decreased after DL-propranolol, but was not changed after D-propranolol. Arterial concentrations of lactate and triglycerides were not influenced by the drugs. 5. The chronotropic response to beta-adrenoceptor blockade appears to be stereoselective, suggesting specific blockade of beta-adrenoceptors. Metabolic responses to beta-adrenoceptor blockade are difficult to explain in terms of the known adrenoceptor system and may be due to non-specific actions of beta-adrenoceptor antagonists. An exception is inhibition of lipolysis, which is probably mediated via beta-adrenoceptors.
Similar articles
-
Haemodynamic and metabolic effects of alpha-adrenoceptor blockade with phentolamine at rest and during forearm exercise.Clin Sci (Lond). 1983 Sep;65(3):247-53. doi: 10.1042/cs0650247. Clin Sci (Lond). 1983. PMID: 6872459
-
Immediate haemodynamic and metabolic effects of intravenous labetalol in the exercising forearm.Postgrad Med J. 1980;56 Suppl 2:17-20. Postgrad Med J. 1980. PMID: 7433337
-
Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.Eur J Clin Invest. 1980 Dec;10(6):431-5. doi: 10.1111/j.1365-2362.1980.tb02081.x. Eur J Clin Invest. 1980. PMID: 6265221
-
Haemodynamic and metabolic effects of diazoxide during rest and forearm exercise.Eur J Clin Pharmacol. 1982;22(2):111-6. doi: 10.1007/BF00542454. Eur J Clin Pharmacol. 1982. PMID: 7094980
-
Clinical pharmacology of pindolol.Am Heart J. 1982 Aug;104(2 Pt 2):346-56. doi: 10.1016/0002-8703(82)90125-9. Am Heart J. 1982. PMID: 6125094 Review.
Cited by
-
Pharmacokinetics and dynamics of penbutolol in humans: evidence for pathway-specific stereoselective clearance.Klin Wochenschr. 1986 Jul 15;64(14):636-41. doi: 10.1007/BF01726915. Klin Wochenschr. 1986. PMID: 3762014 Clinical Trial.
-
Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol and propranolol on plasma levels of adrenaline and noradrenaline.Br J Clin Pharmacol. 1982;13(Suppl 2):391S-395S. doi: 10.1111/j.1365-2125.1982.tb01946.x. Br J Clin Pharmacol. 1982. PMID: 6125191 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources